FdaApplication
NDA 018343
Identifiers
- fda_app_no: NDA018343
Properties
| Property | Value |
|---|---|
| applicant_name | AARXION ANDA HOLDING LLC |
| application_type | NDA |
| approval_date | 1985-01-17 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CAPOTEN | CAPTOPRIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOTEN | CAPTOPRIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
7 products